Dong-ki Lee

Dong-ki Lee

Company: OliX Pharmaceuticals

Job title: Founder & Chief Executive Officer


Reversing Liver Fibrosis: A Combination of Anti-NASH siRNA & Semaglutide 11:00 am

Identifying genomic variants from a large group of patients to derive robust targets Delving into the effects of weight loss to due to energy expenditure compared to incretin-based drugs Disentangling the forthcoming combination studies to increase the efficacy of reversing liver fibrosis and inducing reduction of liver fat contentRead more

day: Day 2 Seminar A Pre-Lunch Tracks

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.